Iron, hepatic stellate cells and fibrosis in chronic hepatitis C

European Journal of Clinical Investigation

Volumn 32, Issue SUPPL. 1, 2002, Pages 28-35

  Rigamonti, Cristina ^a   Andorno, S ^a   Maduli, E ^a   Morelli, S ^a   Pittau, S ^a   Nicosia, G ^b   Boldorini, R ^b   Sartori, M ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Istituto di Anatomia Patologica   (Italy)

Author keywords

Fibrogenesis; Hepatic regeneration; Hepatic stellate cells; Hepatitis C; Iron

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FERRITIN; IRON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; ACTIN; KI 67 ANTIGEN;

ARTICLE; CELL COUNT; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE COURSE; FERRITIN BLOOD LEVEL; FIBROGENESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CELL; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER REGENERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SPECTROPHOTOMETRY; STELLATE CELL; TISSUE DISTRIBUTION; ADULT; AGED; BLOOD; CHEMISTRY; FEMALE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOLOGY;

ACTINS; ADULT; AGED; DISEASE PROGRESSION; FEMALE; FERRITINS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IRON; KI-67 ANTIGEN; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; MIDDLE AGED;

EID: 19044391259     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.0320s1028.x     Document Type: Article

References (49)

1. Di Bisceglie AM. Hepatitis C. Lancet 1998;351:351-5.
2. Pagliaro L, Peri V, Linea C, Cammà C, Giunta M, Magrin S. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol 1999;31:28-44.
3. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-13.
4. Haque S, Chandra B, Gerber MA, Lok AS. Iron overload in patients with chronic hepatitis C. A clinicopathologic study. Hum Pathol 1996;27:1277-81.
5. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997;92: 1298-301.
6. Sartori M, Andorno S, La Terra G, Boldorini R, Leone F, Pittau S, et al. Evaluation of iron status in patients with chronic hepatitis C. Ital J Gastroenterol Hepatol 1998;30:396-401.
7. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C. Hum Pathol 1995;26:1080-5.
8. Ikura Y, Morimoto H, Johmura H, Fukui M, Sakurai M. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996;91:1367-73.
9. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997;25:759-68.
10. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997;41:115-20.
11. Van Thiel DH, Colantoni A, De Maria N. Hepatic iron, serum indices of iron status and chronic hepatitis C. activity, stage and response to therapy. Ital J Gastroenterol Hepatol 1998;30:402-4.
12. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, et al. The relation of iron status and haemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-34.
13. Borysiewicz LK, Graham S, Sissons JG. Human natural killer cells lysis of virus-infected cells. Relationship to expression of the transferrin receptor. Eur J Immunol 1986;16:405-11.
14. Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL. Effects of therapy with interferon-α on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C. Clin Immunol Immunopathol 1994;73:350-7.
15. Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, et al. Hepatic iron overload in patients with chronic hepatitis: role of HFE gene mutations. Hepatology 1998;28:1105-9.
16. Bassett SE, Di Bisceglie AM, Bacon BR, Sharp RM, Govindarajan S, Hubbard GB et al. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology 1999;29:1884-92.
17. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994;89:986-8.
18. Fontana RJ, Israel J, Leclair P, Banner BF, Tortorelli K, Grace N, et al. Iron reduction before and during interferon therapy of chronic hepatitis C. results of a multicenter, randomized, controlled trial. Hepatology 2000;31:730-6.
19. Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, et al. Iron reduction as adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Hepatology 2000;32:135-8.
20. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J Hepatol 1998;28(Suppl.):8-13.
21. Powell LW, Bassett ML, Halliday JW. Haemochromatosis. 1980 update. Gastroenterology 1980;78:374-81.
22. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-35.
23. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, De Bleser P, Montosi G, et al. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of haemochromatosis. Hepatology 1994;19:714-21.
24. Ramm GA, Li SC, Li L, Britton RS, O'Neill R, Kobayashi Y, et al. Chronic iron overload causes activation of rat lipocytes invivo. Am J Physiol 1995;268:G451-8.
25. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, Halliday JW. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997;26:584-92.
26. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997;32:424-30.
27. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990;11:599-605.
28. Knittel T, Müller L, Saile B, Ramadori G. Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. J Hepatol 1997;27:1067-80.
29. Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. Cytokines induce NF-κB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 1998;275:G269-78.
30. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993;194:1044-50.
31. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cell by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461-8.
32. Parola M, Pinzani M, Casini A, Leonarduzzi G, Marra F, Caligiuri A, et al. Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and journal 4-hydroxy-2,3- alkenals is related to their molecular structure. Biochem Biophys Res Commun 1996;222:261-4.
33. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998;27:720-6.
34. Roth S, Michel K, Gressner AM. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 1998;27:1003-12.
35. Sakaida I, Nagatomi A, Hironaka K, Uchida K, Okita K. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Am J Gastroenterol 1999;94:489-96.
36. Deugnier YM, Loréal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic haemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9.
37. Stal P, Hultcrantz R, Moller L, Eriksson LC. The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology 1995;21:521-8.
38. Ito K, Mitchell DG, Gabata T, Hann HW, Kim PN, Fujita T, et al. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. Radiology 1999;212:235-40.
39. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 1997;23:783-92.
40. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-102.
41. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19:1321-4.
42. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
43. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: Macsween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the Liver. 3rd edn. Edinburgh: Churchill Livingstone; 1994, pp. 219-42.
44. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996;25:633-8.
45. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, et al. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-) fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 1999;112:387-401.
46. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A, et al. Hepatic bile duct injuries in chronic hepatitis C, histopathologic and immunohistochemical studies. Mod Pathol 1994;7:937-45.
47. Sartori M, Andorno S, Rigamonti C, Grossini E, Nicosia G, Boldorini R. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol 2000;15:1411-7.
48. Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of effectiveness of venesection for chronic hepatitis C. J Hepatol 1995;22:268-71.
49. Sartori M, Andorno S, La Terra G, Pittau S, Leone F, Saglio G. Phlebotomy reduces serum procollagen III peptide levels in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1999;11:937-9.